Philadelphia [USA], June 13 (ANI): In a breakthrough study, a team of cancer researchers have implied a strategy using the tools used for the development of cancer immunotherapies and adapted them to identify the 'right protein sequences to target in SARS-CoV-2,' the virus that causes cor
Philadelphia [USA], June 9 (ANI): A team of cancer researchers have applied the strategy of using the tools used for the development of cancer immunotherapies and adapted them to identify the 'right protein sequences to target in SARS-CoV-2,' the virus that causes coronavirus.
Washington D.C. [USA], April 12 (ANI): Treating metastatic bladder cancer patients with immunotherapy immediately after their chemotherapy significantly slows down the progression of cancer, suggests a study based on a clinical trial.
Washington D.C.[USA], April 10 (ANI): The results of a clinical trial show using immunotherapy immediately after chemotherapy treatment in patients with metastatic bladder cancer significantly slowed the progression of cancer.
New Delhi [India], Mar 7 (ANI): In a recent study, researchers suggest that gut bacteria can penetrate tumour cells and boost the effectiveness of experimental immunotherapy that targets the CD47 protein. The study focused on the response to cancer immunotherapy and if it depends on bacteri
Washington D.C. [USA], Jan 31 (ANI): Researchers discovered that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusion of anti-tumour immune cells, or T cells, may produce a stronger immune response that could help fight advanced melano
Washington D.C. [USA], Jan 16 (ANI): Researchers have figured out a new method to bypass the blood-brain barrier in situations where it begins to play a counterproductive role by expelling the immune system cell through its drainage system.
Washington D.C. [USA], Dec 24 (ANI): Immune checkpoint inhibitors are important medications that boost the immune system's response against certain cancers; however, they tend to be ineffective against glioblastoma, the most deadly primary brain tumour in adults.
Washington DC [USA], Dec 15 (ANI): Researchers from the QIMR Berghofer Medical Research Institute are a step closer to potential cancer immunotherapy involving switching off a regulatory cell to stop tumours growing and spreading.
Washington DC [USA], Dec 12 (ANI): Researchers from the QIMR Berghofer Medical Research Institute have discovered a potential new cancer immunotherapy target that involves switching off a regulatory cell to stop tumours growing and spreading.
Taipei [Taiwan] Dec 2 (ANI/Digpu): The immunotherapy used by Guang-Li Biomedicine and Taipei Medical University Hospital brings new hope to the terminal patients of solid cancer.
Washington D.C. [USA], Nov 30 (ANI): In what could be a piece of great news for men with advanced prostate cancer, a new study has claimed that they can live two more years or even more on immunotherapy.